{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T11:20:08Z","timestamp":1783077608499,"version":"3.54.6"},"reference-count":280,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,4,30]],"date-time":"2027-04-30T00:00:00Z","timestamp":1809043200000},"content-version":"am","delay-in-days":180,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32460236"],"award-info":[{"award-number":["32460236"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["52303180"],"award-info":[{"award-number":["52303180"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000072","name":"National Institute of Dental and Craniofacial Research","doi-asserted-by":"publisher","award":["R01DE035200"],"award-info":[{"award-number":["R01DE035200"]}],"id":[{"id":"10.13039\/100000072","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R21AR082668"],"award-info":[{"award-number":["R21AR082668"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004479","name":"Jiangxi Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["20252BAC220026"],"award-info":[{"award-number":["20252BAC220026"]}],"id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012259","name":"Major Discipline Academic and Technical Leaders Training Program of Jiangxi Province","doi-asserted-by":"publisher","award":["20204BCJL22052"],"award-info":[{"award-number":["20204BCJL22052"]}],"id":[{"id":"10.13039\/501100012259","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.biomaterials.2026.124231","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T07:00:04Z","timestamp":1776668404000},"page":"124231","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Physiologically relevant 3D tumor models for therapeutic screening"],"prefix":"10.1016","volume":"334","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0523-9702","authenticated-orcid":false,"given":"Renjian","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianqiong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhuri","family":"Dey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4543-370X","authenticated-orcid":false,"given":"Navneet","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0019-010X","authenticated-orcid":false,"given":"Weijie","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8328-4528","authenticated-orcid":false,"given":"Ibrahim T.","family":"Ozbolat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.biomaterials.2026.124231_bib1","article-title":"3D biomimetic models to reconstitute tumor microenvironment in vitro: spheroids, organoids, and tumor-on-a-chip","volume":"12","author":"Li","year":"2023","journal-title":"Adv. Healthcare Mater."},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124231_bib2","doi-asserted-by":"crossref","DOI":"10.1088\/1758-5090\/acd1b8","article-title":"Reconstruction of tumor microenvironment via in vitro three-dimensional models","volume":"15","author":"Zhou","year":"2023","journal-title":"Biofabrication"},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124231_bib3","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124231_bib4","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Freddie Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"5","key":"10.1016\/j.biomaterials.2026.124231_bib5","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.tibtech.2023.11.006","article-title":"Converging bioprinting and organoids to better recapitulate the tumor microenvironment","volume":"42","author":"Wang","year":"2024","journal-title":"Trends Biotechnol."},{"issue":"12","key":"10.1016\/j.biomaterials.2026.124231_bib6","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41568-022-00514-w","article-title":"3D bioprinted cancer models: from basic biology to drug development","volume":"22","author":"Neufeld","year":"2022","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124231_bib7","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41577-023-00896-4","article-title":"Harnessing 3D in vitro systems to model immune responses to solid tumours: a step towards improving and creating personalized immunotherapies","volume":"24","author":"Zhou","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biomaterials.2026.124231_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.bprint.2023.e00316","article-title":"Complexity in in-vitro tumor microenvironment reconstruction for drug screening and personalized medicine","volume":"36","author":"Ghosh","year":"2023","journal-title":"Bioprinting"},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124231_bib9","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","article-title":"The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth","volume":"41","author":"de Visser","year":"2023","journal-title":"Cancer Cell"},{"issue":"19","key":"10.1016\/j.biomaterials.2026.124231_bib10","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.3390\/cells13191666","article-title":"Beyond cancer cells: how the tumor microenvironment drives cancer progression","volume":"13","author":"Sabit","year":"2024","journal-title":"Cells"},{"issue":"16","key":"10.1016\/j.biomaterials.2026.124231_bib11","doi-asserted-by":"crossref","first-page":"R921","DOI":"10.1016\/j.cub.2020.06.081","article-title":"The tumor microenvironment","volume":"30","author":"Anderson","year":"2020","journal-title":"Curr. Biol."},{"issue":"19","key":"10.1016\/j.biomaterials.2026.124231_bib12","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1093\/jnci\/djm135","article-title":"Drug resistance and the solid tumor microenvironment","volume":"99","author":"Tredan","year":"2007","journal-title":"JNCI Journal of the National Cancer Institute"},{"key":"10.1016\/j.biomaterials.2026.124231_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216894","article-title":"Unraveling the tumor microenvironment: insights into cancer metastasis and therapeutic strategies","volume":"591","author":"El-Tanani","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biomaterials.2026.124231_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2019.110264","article-title":"Comparison of 2D and 3D cell culture models for cell growth, gene expression and drug resistance","volume":"107","author":"Fontoura","year":"2020","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.biomaterials.2026.124231_bib15","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.2147\/CMAR.S302565","article-title":"Application of animal models in cancer research: recent progress and future prospects","volume":"13","author":"Li","year":"2021","journal-title":"Cancer Manag. Res."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124231_bib16","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/bit.26845","article-title":"3D tumor spheroids as in vitro models to mimic in vivo human solid tumors resistance to therapeutic drugs","volume":"116","author":"Nunes","year":"2018","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.biomaterials.2026.124231_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122504","article-title":"Patient-derived tumor spheroid-induced angiogenesis preclinical platform for exploring therapeutic vulnerabilities in cancer","volume":"306","author":"Ko","year":"2024","journal-title":"Biomaterials"},{"issue":"8","key":"10.1016\/j.biomaterials.2026.124231_bib18","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/s41568-024-00706-6","article-title":"Cancer organoids 2.0: modelling the complexity of the tumour immune microenvironment","volume":"24","author":"Polak","year":"2024","journal-title":"Nat. Rev. Cancer"},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124231_bib19","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.7150\/thno.91362","article-title":"Construction of tumor organoids and their application to cancer research and therapy","volume":"14","author":"Lv","year":"2024","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124231_bib20","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12929-024-00994-y","article-title":"Scaffold-based 3D cell culture models in cancer research","volume":"31","author":"Abuwatfa","year":"2024","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.biomaterials.2026.124231_bib21","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.biomaterials.2018.05.020","article-title":"High throughput scaffold-based 3D micro-tumor array for efficient drug screening and chemosensitivity testing","volume":"198","author":"Yan","year":"2019","journal-title":"Biomaterials"},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124231_bib22","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/s44222-024-00163-8","article-title":"Microfluidic high-throughput 3D cell culture","volume":"2","author":"Ko","year":"2024","journal-title":"Nat. Rev. Bioeng."},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124231_bib23","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41568-018-0104-6","article-title":"Modelling cancer in microfluidic human organs-on-chips","volume":"19","author":"Sontheimer-Phelps","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biomaterials.2026.124231_bib24","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.addr.2014.07.002","article-title":"Microfluidic 3D models of cancer","volume":"79\u201380","author":"Sung","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124231_bib25","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202304460","article-title":"Prediction of clinical precision chemotherapy by patient\u2010derived 3D bioprinting models of colorectal cancer and its liver metastases","volume":"11","author":"Sun","year":"2023","journal-title":"Adv. Sci."},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124231_bib26","doi-asserted-by":"crossref","DOI":"10.1088\/1758-5090\/ac6d11","article-title":"Mimicking tumor microenvironment by 3D bioprinting: 3D cancer modeling","volume":"14","author":"Shukla","year":"2022","journal-title":"Biofabrication"},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124231_bib27","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1007\/s42242-024-00317-y","article-title":"3D bioprinting of tumor models and potential applications","volume":"7","author":"Li","year":"2024","journal-title":"BioDes. Manuf."},{"key":"10.1016\/j.biomaterials.2026.124231_bib28","first-page":"141","article-title":"Drug resistance and combating drug resistance in cancer","volume":"2","author":"Wang","year":"2019","journal-title":"Cancer Drug Resistance"},{"issue":"10","key":"10.1016\/j.biomaterials.2026.124231_bib29","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/s41571-025-01059-1","article-title":"Understanding and overcoming multidrug resistance in cancer","volume":"22","author":"Ge","year":"2025","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.biomaterials.2026.124231_bib30","first-page":"1408","article-title":"The unique physiology of solid tumors: opportunities (and problems) for cancer therapy","volume":"58","author":"Giaccia","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/j.biomaterials.2026.124231_bib31","article-title":"Interplay between solid tumors and tumor microenvironment","volume":"13","author":"Kim","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biomaterials.2026.124231_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117585","article-title":"Physiological and tumor-associated angiogenesis: key factors and therapy targeting VEGF\/VEGFR pathway","volume":"180","author":"Lorenc","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124231_bib33","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1007\/s00018-019-03351-7","article-title":"Tumor angiogenesis: causes, consequences, challenges and opportunities","volume":"77","author":"Lugano","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.biomaterials.2026.124231_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122428","article-title":"Engineered 3D ex vivo models to recapitulate the complex stromal and immune interactions within the tumor microenvironment","volume":"305","author":"Ravi","year":"2024","journal-title":"Biomaterials"},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124231_bib35","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1158\/2159-8290.CD-20-1808","article-title":"Therapeutic targeting of the tumor microenvironment","volume":"11","author":"Bejarano","year":"2021","journal-title":"Cancer Discov."},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124231_bib36","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ccell.2023.01.009","article-title":"Metabolic programming and immune suppression in the tumor microenvironment","volume":"41","author":"Arner","year":"2023","journal-title":"Cancer Cell"},{"issue":"7203","key":"10.1016\/j.biomaterials.2026.124231_bib37","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"Mantovani","year":"2008","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124231_bib38","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/nrc.2016.73","article-title":"The biology and function of fibroblasts in cancer","volume":"16","author":"Kalluri","year":"2016","journal-title":"Nat. Rev. Cancer"},{"issue":"10","key":"10.1016\/j.biomaterials.2026.124231_bib39","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/s41568-024-00740-4","article-title":"CAF-induced physical constraints controlling T cell state and localization in solid tumours","volume":"24","author":"Arpinati","year":"2024","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124231_bib40","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/s41392-021-00544-0","article-title":"Extracellular matrix and its therapeutic potential for cancer treatment","volume":"6","author":"Huang","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.biomaterials.2026.124231_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2024.1384567","article-title":"Editorial: new advancement in tumor microenvironment remodeling and cancer therapy","volume":"12","author":"Yao","year":"2024","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.biomaterials.2026.124231_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.960317","article-title":"Cancer chemotherapy: insights into cellular and tumor microenvironmental mechanisms of action","volume":"12","author":"Tilsed","year":"2022","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124231_bib43","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1186\/s13046-019-1225-9","article-title":"Multiplex quantitative analysis of stroma-mediated cancer cell invasion, matrix remodeling, and drug response in a 3D co-culture model of pancreatic tumor spheroids and stellate cells","volume":"38","author":"Hwang","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"7","key":"10.1016\/j.biomaterials.2026.124231_bib44","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1038\/s43018-024-00775-4","article-title":"Tumor-associated macrophages restrict CD8+ T cell function through collagen deposition and metabolic reprogramming of the breast cancer microenvironment","volume":"5","author":"Tharp","year":"2024","journal-title":"Nat. Cancer"},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124231_bib45","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.3390\/pharmaceutics15041143","article-title":"Cancer resistance to immunotherapy: comprehensive insights with future perspectives","volume":"15","author":"Said","year":"2023","journal-title":"Pharmaceutics"},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124231_bib46","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","article-title":"Immune landscape of cancer","volume":"48","author":"Thorsson","year":"2018","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124231_bib47","doi-asserted-by":"crossref","first-page":"5361","DOI":"10.1038\/s41467-018-07767-w","article-title":"Local mutational diversity drives intratumoral immune heterogeneity in non-small cell lung cancer","volume":"9","author":"Jia","year":"2018","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124231_bib48","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s12964-023-01183-4","article-title":"Anoikis resistance\u2013\u2013protagonists of breast cancer cells survive and metastasize after ECM detachment","volume":"21","author":"Dai","year":"2023","journal-title":"Cell Commun. Signal."},{"issue":"14","key":"10.1016\/j.biomaterials.2026.124231_bib49","doi-asserted-by":"crossref","first-page":"6499","DOI":"10.1021\/acs.chemrev.8b00042","article-title":"Mechanobiology of tumor growth","volume":"118","author":"Chaudhuri","year":"2018","journal-title":"Chem. Rev."},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124231_bib50","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s42254-024-00707-2","article-title":"Mechanical properties of human tumour tissues and their implications for cancer development","volume":"6","author":"Massey","year":"2024","journal-title":"Nat. Rev. Phys."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124231_bib51","first-page":"10","article-title":"Cancer cell mechanobiology: a new frontier for cancer research","volume":"2","author":"Yu","year":"2022","journal-title":"J. Natl. Cancer Cent."},{"issue":"47","key":"10.1016\/j.biomaterials.2026.124231_bib52","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1038\/s41388-023-02844-x","article-title":"Biophysics in tumor growth and progression: from single mechano-sensitive molecules to mechanomedicine","volume":"42","author":"Xin","year":"2023","journal-title":"Oncogene"},{"issue":"11","key":"10.1016\/j.biomaterials.2026.124231_bib53","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.trecan.2023.07.006","article-title":"Beyond matrix stiffness: targeting force-induced cancer drug resistance","volume":"9","author":"Kalli","year":"2023","journal-title":"Trends Cancer"},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124231_bib54","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nrc.2017.118","article-title":"EMT in cancer","volume":"18","author":"Brabletz","year":"2018","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124231_bib55","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s13045-022-01349-6","article-title":"TGF-\u03b2 signaling in the tumor metabolic microenvironment and targeted therapies","volume":"15","author":"Shi","year":"2022","journal-title":"J. Hematol. Oncol."},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124231_bib56","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1515\/mr-2021-0014","article-title":"Tumor-associated macrophages, dendritic cells, and neutrophils: biological roles, crosstalk, and therapeutic relevance","volume":"1","author":"Shen","year":"2021","journal-title":"Medical Review"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124231_bib57","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/s41392-021-00670-9","article-title":"Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer","volume":"6","author":"Li","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124231_bib58","doi-asserted-by":"crossref","first-page":"6966","DOI":"10.1038\/s41467-023-42382-4","article-title":"Cancer-associated fibroblasts actively compress cancer cells and modulate mechanotransduction","volume":"14","author":"Barbazan","year":"2023","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124231_bib59","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s12943-023-01876-x","article-title":"Pan-cancer spatially resolved single-cell analysis reveals the crosstalk between cancer-associated fibroblasts and tumor microenvironment","volume":"22","author":"Ma","year":"2023","journal-title":"Mol. Cancer"},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124231_bib60","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s12015-024-10701-x","article-title":"Alternatives of animal models for biomedical research: a comprehensive review of modern approaches","volume":"20","author":"Vashishat","year":"2024","journal-title":"Stem Cell Rev. Rep."},{"issue":"11","key":"10.1016\/j.biomaterials.2026.124231_bib61","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/s41684-024-01458-4","article-title":"The continued importance of animals in biomedical research","volume":"53","author":"Chang","year":"2024","journal-title":"Lab. Anim."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124231_bib62","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ctrv.2010.05.001","article-title":"The unique characteristics of tumor vasculature and preclinical evidence for its selective disruption by tumor-vascular disrupting agents","volume":"37","author":"Siemann","year":"2011","journal-title":"Cancer Treat Rev."},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124231_bib63","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s10456-017-9562-9","article-title":"Tumor angiogenesis and vascular normalization: alternative therapeutic targets","volume":"20","author":"Viallard","year":"2017","journal-title":"Angiogenesis"},{"issue":"15","key":"10.1016\/j.biomaterials.2026.124231_bib64","doi-asserted-by":"crossref","first-page":"5223","DOI":"10.7150\/thno.84947","article-title":"Visualizing vasculature and its response to therapy in the tumor microenvironment","volume":"13","author":"Lin","year":"2023","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124231_bib65","doi-asserted-by":"crossref","first-page":"4596","DOI":"10.1038\/s41467-024-48666-7","article-title":"Mapping the landscape of histomorphological cancer phenotypes using self-supervised learning on unannotated pathology slides","volume":"15","author":"Claudio Quiros","year":"2024","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124231_bib66","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3109\/03009734.2012.659294","article-title":"Cancer cell differentiation heterogeneity and aggressive behavior in solid tumors","volume":"117","author":"J\u00f6gi","year":"2012","journal-title":"Upsala J. Med. Sci."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124231_bib67","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12916-015-0278-7","article-title":"New Horizons in tumor microenvironment biology: challenges and opportunities","volume":"13","author":"Chen","year":"2015","journal-title":"BMC Med."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124231_bib68","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41392-023-01332-8","article-title":"Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions","volume":"8","author":"Chen","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124231_bib69","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.chembiol.2023.08.011","article-title":"Tumor microenvironmental nutrients, cellular responses, and cancer","volume":"30","author":"Lobel","year":"2023","journal-title":"Cell Chem. Biol."},{"issue":"7069","key":"10.1016\/j.biomaterials.2026.124231_bib70","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/nature04186","article-title":"VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche","volume":"438","author":"Kaplan","year":"2005","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124231_bib71","doi-asserted-by":"crossref","DOI":"10.1002\/cai2.102","article-title":"A comprehensive review of 3D cancer models for drug screening and translational research","volume":"3","author":"Sharma","year":"2023","journal-title":"Cancer Innovation"},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124231_bib72","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1038\/s41592-025-02769-1","article-title":"From 2D to 3D and beyond: the evolution and impact of in vitro tumor models in cancer research","volume":"22","author":"Rauner","year":"2025","journal-title":"Nat. Methods"},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124231_bib73","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s12032-025-02641-4","article-title":"Tumor microenvironment: recent advances in understanding and its role in modulating cancer therapies","volume":"42","author":"Shah","year":"2025","journal-title":"Med. Oncol."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124231_bib74","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41698-022-00272-w","article-title":"Tumor microenvironment heterogeneity an important mediator of prostate cancer progression and therapeutic resistance","volume":"6","author":"Ge","year":"2022","journal-title":"npj Precis. Oncol."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124231_bib75","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s43556-025-00352-w","article-title":"Drug resistance in cancer: molecular mechanisms and emerging treatment strategies","volume":"6","author":"Li","year":"2025","journal-title":"Molecular Biomedicine"},{"issue":"7782","key":"10.1016\/j.biomaterials.2026.124231_bib76","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41586-019-1730-1","article-title":"A view on drug resistance in cancer","volume":"575","author":"Vasan","year":"2019","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124231_bib77","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1007\/s42242-021-00134-7","article-title":"3D tumor model biofabrication","volume":"4","author":"Li","year":"2021","journal-title":"BioDes. Manuf."},{"issue":"24","key":"10.1016\/j.biomaterials.2026.124231_bib78","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202200690","article-title":"Advances in 3D bioprinting for cancer biology and precision medicine: from matrix design to application","volume":"11","author":"Jung","year":"2022","journal-title":"Adv. Healthcare Mater."},{"issue":"8","key":"10.1016\/j.biomaterials.2026.124231_bib79","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/j.biotechadv.2016.11.002","article-title":"3D tumor spheroids: an overview on the tools and techniques used for their analysis","volume":"34","author":"Costa","year":"2016","journal-title":"Biotechnol. Adv."},{"issue":"19","key":"10.1016\/j.biomaterials.2026.124231_bib80","doi-asserted-by":"crossref","first-page":"4846","DOI":"10.3390\/cancers15194846","article-title":"Three-dimensional in vitro tumor spheroid models for evaluation of anticancer therapy: recent updates","volume":"15","author":"Nayak","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.biomaterials.2026.124231_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.123184","article-title":"Multicellular tumor spheroids: a convenient in vitro model for translational cancer research","volume":"358","author":"Patel","year":"2024","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124231_bib82","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/cas.13155","article-title":"Tumor-derived spheroids: relevance to cancer stem cells and clinical applications","volume":"108","author":"Ishiguro","year":"2017","journal-title":"Cancer Sci."},{"issue":"19","key":"10.1016\/j.biomaterials.2026.124231_bib83","doi-asserted-by":"crossref","first-page":"5259","DOI":"10.7150\/thno.29098","article-title":"Chemoresistance of cancer cells: requirements of tumor microenvironment-mimicking in vitro models in anti-cancer drug development","volume":"8","author":"Jo","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.biomaterials.2026.124231_bib84","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.biomaterials.2018.02.030","article-title":"3D-3-culture: a tool to unveil macrophage plasticity in the tumour microenvironment","volume":"163","author":"Rebelo","year":"2018","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124231_bib85","doi-asserted-by":"crossref","DOI":"10.1088\/1758-5090\/abe6f2","article-title":"Cell spheroids as a versatile research platform: formation mechanisms, high throughput production, characterization and applications","volume":"13","author":"Decarli","year":"2021","journal-title":"Biofabrication"},{"issue":"12","key":"10.1016\/j.biomaterials.2026.124231_bib86","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1038\/nm.4238","article-title":"Patient-derived induced pluripotent stem cells in cancer research and precision oncology","volume":"22","author":"Papapetrou","year":"2016","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124231_bib87","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s43586-022-00174-y","article-title":"Organoids","volume":"2","author":"Zhao","year":"2022","journal-title":"Nat. Rev. Methods Primers"},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124231_bib88","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/s41578-019-0129-9","article-title":"Engineered materials for organoid systems","volume":"4","author":"Kratochvil","year":"2019","journal-title":"Nat. Rev. Mater."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124231_bib89","doi-asserted-by":"crossref","DOI":"10.1038\/s41420-017-0009-2","article-title":"Modeling cancer using patient-derived induced pluripotent stem cells to understand development of childhood malignancies","volume":"4","author":"Marin Navarro","year":"2018","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.biomaterials.2026.124231_bib90","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.728543","article-title":"iPSC-Derived organoids as therapeutic models in regenerative medicine and oncology","volume":"8","author":"Turhan","year":"2021","journal-title":"Front. Med."},{"issue":"7","key":"10.1016\/j.biomaterials.2026.124231_bib91","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1038\/s12276-024-01272-5","article-title":"Patient-derived tumor organoids: a new avenue for preclinical research and precision medicine in oncology","volume":"56","author":"Thorel","year":"2024","journal-title":"Exp. Mol. Med."},{"issue":"13","key":"10.1016\/j.biomaterials.2026.124231_bib92","doi-asserted-by":"crossref","first-page":"7081","DOI":"10.3390\/ijms22137081","article-title":"The role of small molecules and their effect on the molecular mechanisms of early retinal organoid development","volume":"22","author":"Wagstaff","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124231_bib93","doi-asserted-by":"crossref","DOI":"10.1002\/INMD.20240083","article-title":"A facile automated multiple\u2010well platform of immunized tumor organoid cultures in ECM\u2010mimicked hydrogels for chem\u2010immunotherapy evaluation","volume":"3","author":"Tang","year":"2025","journal-title":"Interdisciplinary Medicine"},{"key":"10.1016\/j.biomaterials.2026.124231_bib94","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2025.1569337","article-title":"Organoids technology in cancer research: from basic applications to advanced ex vivo models","volume":"13","author":"Varinelli","year":"2025","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124231_bib95","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1038\/s41598-023-29065-2","article-title":"Tumor organoid biobank-new platform for medical research","volume":"13","author":"Xie","year":"2023","journal-title":"Scientic Reports"},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124231_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.engmed.2025.100089","article-title":"Organoids pharmacology and toxicology","volume":"2","author":"Sun","year":"2025","journal-title":"EngMedicine"},{"issue":"6378","key":"10.1016\/j.biomaterials.2026.124231_bib97","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1126\/science.aao2774","article-title":"Patient-derived organoids model treatment response of metastatic gastrointestinal cancers","volume":"359","author":"Georgios Vlachogiannis","year":"2018","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.biomaterials.2026.124231_bib98","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.tibtech.2017.06.015","article-title":"Engineered hydrogels in cancer therapy and diagnosis","volume":"35","author":"Sepantafar","year":"2017","journal-title":"Trends Biotechnol."},{"issue":"11","key":"10.1016\/j.biomaterials.2026.124231_bib99","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.tibtech.2015.09.009","article-title":"Evaluating Biomaterial- and microfluidic-based 3D tumor models","volume":"33","author":"Carvalho","year":"2015","journal-title":"Trends Biotechnol."},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124231_bib100","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.3390\/molecules27092902","article-title":"Hydrogels: properties and applications in biomedicine","volume":"27","author":"Ho","year":"2022","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124231_bib101","doi-asserted-by":"crossref","DOI":"10.1016\/j.engmed.2025.100092","article-title":"Biomaterial-mediated modulation of tumor microenvironment and therapeutic sensitization","volume":"2","author":"Qiao","year":"2025","journal-title":"EngMedicine"},{"issue":"5","key":"10.1016\/j.biomaterials.2026.124231_bib102","article-title":"Engineering mesoscopic 3D tumor models with a self\u2010organizing vascularized matrix","volume":"36","author":"De Lorenzi","year":"2023","journal-title":"Adv. Mater."},{"issue":"19","key":"10.1016\/j.biomaterials.2026.124231_bib103","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202202984","article-title":"Impact of fibrinogen, fibrin thrombi, and thrombin on cancer cell extravasation using in vitro microvascular networks","volume":"12","author":"Angelidakis","year":"2023","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.biomaterials.2026.124231_bib104","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2024.122363","article-title":"An integrative alginate-based 3D in vitro model to explore epithelial-stromal cell dynamics in the breast tumor microenvironment","volume":"342","author":"Barros da Silva","year":"2024","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.biomaterials.2026.124231_bib105","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.actbio.2019.06.017","article-title":"3D bioprinted mammary organoids and tumoroids in human mammary derived ECM hydrogels","volume":"95","author":"Mollica","year":"2019","journal-title":"Acta Biomater."},{"issue":"5","key":"10.1016\/j.biomaterials.2026.124231_bib106","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.3390\/cancers14051225","article-title":"Reductionist three-dimensional tumor microenvironment models in synthetic hydrogels","volume":"14","author":"Katz","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.biomaterials.2026.124231_bib107","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.actbio.2018.06.003","article-title":"Hybrid collagen alginate hydrogel as a platform for 3D tumor spheroid invasion","volume":"75","author":"Liu","year":"2018","journal-title":"Acta Biomater."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124231_bib108","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/s41392-021-00830-x","article-title":"Current hydrogel advances in physicochemical and biological response-driven biomedical application diversity","volume":"6","author":"Cao","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"5","key":"10.1016\/j.biomaterials.2026.124231_bib109","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.stem.2022.03.013","article-title":"Programming hydrogels to probe spatiotemporal cell biology","volume":"29","author":"Qazi","year":"2022","journal-title":"Cell Stem Cell"},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124231_bib110","doi-asserted-by":"crossref","first-page":"238","DOI":"10.3390\/gels10040238","article-title":"Advancements and challenges in hydrogel engineering for regenerative medicine","volume":"10","author":"Omidian","year":"2024","journal-title":"Gels"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124231_bib111","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1186\/s12964-024-01884-4","article-title":"Tumor-microenvironment-on-a-chip: the construction and application","volume":"22","author":"Xu","year":"2024","journal-title":"Cell Commun. Signal."},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124231_bib112","doi-asserted-by":"crossref","DOI":"10.1002\/adtp.202300410","article-title":"An overview of advancements and technologies in vascularization strategies for tumor\u2010on\u2010a\u2010chip models","volume":"7","author":"Parihar","year":"2024","journal-title":"Adv. Therapeut."},{"issue":"8","key":"10.1016\/j.biomaterials.2026.124231_bib113","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1039\/c3lc41320a","article-title":"Engineering of functional, perfusable 3D microvascular networks on a chip","volume":"13","author":"Kim","year":"2013","journal-title":"Lab Chip"},{"key":"10.1016\/j.biomaterials.2026.124231_bib114","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120592","article-title":"A novel 3D vascular assay for evaluating angiogenesis across porous membranes","volume":"268","author":"Bai","year":"2021","journal-title":"Biomaterials"},{"issue":"17","key":"10.1016\/j.biomaterials.2026.124231_bib115","doi-asserted-by":"crossref","first-page":"6712","DOI":"10.1073\/pnas.1221526110","article-title":"Biomimetic model to reconstitute angiogenic sprouting morphogenesis in vitro","volume":"110","author":"Nguyen","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.biomaterials.2026.124231_bib116","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.biomaterials.2015.11.019","article-title":"Three-dimensional biomimetic model to reconstitute sprouting lymphangiogenesis in vitro","volume":"78","author":"Kim","year":"2016","journal-title":"Biomaterials"},{"issue":"12","key":"10.1016\/j.biomaterials.2026.124231_bib117","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1158\/0008-5472.CAN-18-2293","article-title":"A human organotypic microfluidic tumor model permits investigation of the interplay between patient-derived fibroblasts and breast cancer cells","volume":"79","author":"Truong","year":"2019","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124231_bib118","first-page":"266","article-title":"The microenvironment of solid tumors: components and current challenges of Tumor-on-a-Chip models","volume":"31","author":"Souza","year":"2024","journal-title":"Tissue Eng., Part B"},{"key":"10.1016\/j.biomaterials.2026.124231_bib119","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.eng.2024.04.023","article-title":"Progress in organ bioprinting for regenerative medicine","volume":"42","author":"Wang","year":"2024","journal-title":"Engineering"},{"key":"10.1016\/j.biomaterials.2026.124231_bib120","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122408","article-title":"A comprehensive review on 3D tissue models: biofabrication technologies and preclinical applications","volume":"304","author":"Xie","year":"2024","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2026.124231_bib121","article-title":"The synergy of artificial intelligence and 3D bioprinting: unlocking new frontiers in precision and tissue fabrication","author":"Robazzi","year":"2025","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.biomaterials.2026.124231_bib122","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2025.123704","article-title":"Unconventional bioprinting modalities for advanced tissue biofabrication","volume":"326","author":"Derman","year":"2026","journal-title":"Biomaterials"},{"issue":"7","key":"10.1016\/j.biomaterials.2026.124231_bib123","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/s41551-019-0363-x","article-title":"A bioprinted human-glioblastoma-on-a-chip for the identification of patient-specific responses to chemoradiotherapy","volume":"3","author":"Yi","year":"2019","journal-title":"Nat. Biomed. Eng."},{"issue":"23","key":"10.1016\/j.biomaterials.2026.124231_bib124","article-title":"3D bioprinting: from benches to translational applications","volume":"15","author":"Heinrich","year":"2019","journal-title":"Small"},{"issue":"19","key":"10.1016\/j.biomaterials.2026.124231_bib125","doi-asserted-by":"crossref","first-page":"3124","DOI":"10.1002\/adma.201305506","article-title":"3D bioprinting of vascularized, heterogeneous cell\u2010laden tissue constructs","volume":"26","author":"Kolesky","year":"2014","journal-title":"Adv. Mater."},{"issue":"8","key":"10.1016\/j.biomaterials.2026.124231_bib126","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/nbt.2958","article-title":"3D bioprinting of tissues and organs","volume":"32","author":"Murphy","year":"2014","journal-title":"Nat. Biotechnol."},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124231_bib127","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.biotechadv.2016.12.006","article-title":"The bioink: a comprehensive review on bioprintable materials","volume":"35","author":"Hospodiuk","year":"2017","journal-title":"Biotechnol. Adv."},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124231_bib143","doi-asserted-by":"crossref","DOI":"10.1088\/1758-5090\/acd95f","article-title":"3D bioprinted vascularized lung cancer organoid models with underlying disease capable of more precise drug evaluation","volume":"15","author":"Choi","year":"2023","journal-title":"Biofabrication"},{"issue":"8","key":"10.1016\/j.biomaterials.2026.124231_bib158","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1039\/D5LC00015G","article-title":"Elevated interstitial flow in the cerebrospinal fluid microenvironment accelerates glioblastoma cell migration on a microfluidic chip","volume":"25","author":"Hu","year":"2025","journal-title":"Lab Chip"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124231_bib159","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202405511","article-title":"Recent developments in glioblastoma\u2010on\u2010a\u2010chip for advanced drug screening applications","volume":"21","author":"Maity","year":"2024","journal-title":"Small"},{"key":"10.1016\/j.biomaterials.2026.124231_bib160","doi-asserted-by":"crossref","DOI":"10.1016\/j.bios.2022.115003","article-title":"Gold nanostructure-integrated conductive microwell arrays for uniform cancer spheroid formation and electrochemical drug screening","volume":"222","author":"Ju","year":"2023","journal-title":"Biosens. Bioelectron."},{"issue":"8","key":"10.1016\/j.biomaterials.2026.124231_bib161","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.3390\/ijms21082993","article-title":"3D bioprinted vascularized tumour for drug testing","volume":"21","author":"Han","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biomaterials.2026.124231_bib162","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.mtchem.2018.12.005","article-title":"Bioprinting a novel glioblastoma tumor model using a fibrin-based bioink for drug screening","volume":"12","author":"Lee","year":"2019","journal-title":"Mater. Today Chem."},{"issue":"23","key":"10.1016\/j.biomaterials.2026.124231_bib163","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2118697119","article-title":"A predictive microfluidic model of human glioblastoma to assess trafficking of blood-brain barrier-penetrant nanoparticles","volume":"119","author":"Straehla","year":"2022","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124231_bib164","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.tips.2019.07.001","article-title":"Tumor vasculatures: a new target for cancer immunotherapy","volume":"40","author":"Liu","year":"2019","journal-title":"Trends Pharmacol. Sci."},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124231_bib153","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.3390\/pharmaceutics15061691","article-title":"3D porous scaffold-based high-throughput platform for cancer drug screening","volume":"15","author":"Zhou","year":"2023","journal-title":"Pharmaceutics"},{"issue":"8","key":"10.1016\/j.biomaterials.2026.124231_bib165","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1172\/JCI124979","article-title":"The antibiotic clofoctol suppresses glioma stem cell proliferation by activating KLF13","volume":"129","author":"Hu","year":"2019","journal-title":"J. Clin. Investig."},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124231_bib206","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.stem.2018.09.016","article-title":"A comprehensive human gastric cancer organoid biobank captures tumor subtype heterogeneity and enables therapeutic screening","volume":"23","author":"Yan","year":"2018","journal-title":"Cell Stem Cell"},{"issue":"6378","key":"10.1016\/j.biomaterials.2026.124231_bib207","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1126\/science.aao2774","article-title":"Patient-derived organoids model treatment response of metastatic gastrointestinal cancers","volume":"359","author":"Vlachogiannis","year":"2018","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124231_bib208","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41420-021-00803-7","article-title":"Establishment of gastric signet ring cell carcinoma organoid for the therapeutic drug testing","volume":"8","author":"Li","year":"2022","journal-title":"Cell Death Discov."},{"issue":"11","key":"10.1016\/j.biomaterials.2026.124231_bib210","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1007\/s00432-019-03004-z","article-title":"Malignant ascites-derived organoid (MADO) cultures for gastric cancer in vitro modelling and drug screening","volume":"145","author":"Li","year":"2019","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124231_bib209","doi-asserted-by":"crossref","first-page":"447","DOI":"10.3892\/ol.2022.13567","article-title":"Establishment of gastric cancer organoid and its application in individualized therapy","volume":"24","author":"Miao","year":"2022","journal-title":"Oncol. Lett."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124231_bib211","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jcmgh.2018.09.008","article-title":"An organoid-based preclinical model of human gastric cancer","volume":"7","author":"Steele","year":"2019","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124231_bib212","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3390\/cells11020184","article-title":"Generation of human stomach cancer iPSC-Derived organoids induced by Helicobacter pylori infection and their application to gastric cancer research","volume":"11","author":"Ku","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.biomaterials.2026.124231_bib213","article-title":"Microfluidic printed 3D bioactive scaffolds for postoperative treatment of gastric cancer","volume":"24","author":"Li","year":"2024","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.biomaterials.2026.124231_bib214","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1356144","article-title":"Evaluation of tumor response to immune checkpoint inhibitors by a 3D immunotumoroid model","volume":"15","author":"Pezeshki","year":"2024","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.biomaterials.2026.124231_bib215","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1038\/s41416-024-02665-z","article-title":"Neratinib could be effective as monotherapy or in combination with trastuzumab in HER2-low breast cancer cells and organoid models","volume":"130","author":"Arshad","year":"2024","journal-title":"Br. J. Cancer"},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124231_bib216","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3390\/ph17020225","article-title":"Unveiling epigenetic vulnerabilities in triple-negative breast cancer through 3D organoid drug screening","volume":"17","author":"Rao","year":"2024","journal-title":"Pharmaceuticals"},{"issue":"21","key":"10.1016\/j.biomaterials.2026.124231_bib217","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202300164","article-title":"In vitro 3D spheroid model preserves tumor microenvironment of hot and cold breast cancer subtypes","volume":"12","author":"Dhandapani","year":"2023","journal-title":"Adv. Healthcare Mater."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124231_bib218","doi-asserted-by":"crossref","DOI":"10.1080\/14756366.2024.2343352","article-title":"The activity of pyrazolo[4,3- e ][1,2,4]triazine and pyrazolo[4,3- e ]tetrazolo[1,5- b ][1,2,4]triazine sulphonamide derivatives in monolayer and spheroid breast cancer cell cultures","volume":"39","author":"Szymanowska","year":"2024","journal-title":"J. Enzym. Inhib. Med. Chem."},{"issue":"14","key":"10.1016\/j.biomaterials.2026.124231_bib219","doi-asserted-by":"crossref","first-page":"3434","DOI":"10.1039\/D4LC00296B","article-title":"Impact of brain organoid-derived sEVs on metastatic adaptation and invasion of breast carcinoma cells through a microphysiological system","volume":"24","author":"Nazari","year":"2024","journal-title":"Lab Chip"},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124231_bib220","doi-asserted-by":"crossref","DOI":"10.1088\/1758-5090\/ad586b","article-title":"Assessment and process optimization of high throughput biofabrication of immunocompetent breast cancer model for drug screening applications","volume":"16","author":"Shukla","year":"2024","journal-title":"Biofabrication"},{"issue":"7","key":"10.1016\/j.biomaterials.2026.124231_bib221","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.stem.2024.04.018","article-title":"Breast cancer-on-chip for patient-specific efficacy and safety testing of CAR-T cells","volume":"31","author":"Maulana","year":"2024","journal-title":"Cell Stem Cell"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124231_bib222","article-title":"Validation of hyperthermia as an enhancer of chemtherapeutic efficacy: insights from a bladder cancer organoid model","volume":"40","author":"Ying Xu","year":"2024","journal-title":"Int. J. Hyperther."},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124231_bib223","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202317613","article-title":"Patient\u2010derived immunocompetent tumor organoids: a platform for chemotherapy evaluation in the context of t\u2010cell recognition","volume":"63","author":"Zhao","year":"2024","journal-title":"Angew. Chem. Int. Ed."},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124231_bib224","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3892\/or.2023.8567","article-title":"CUDC-907 suppresses epithelial-mesenchymal transition, migration and invasion in a 3D spheroid model of bladder cancer","volume":"49","author":"Ho","year":"2023","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.biomaterials.2026.124231_bib225","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jare.2022.07.012","article-title":"Medical gas plasma augments bladder cancer cell toxicity in preclinical models and patient-derived tumor tissues","volume":"47","author":"Gelbrich","year":"2023","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.biomaterials.2026.124231_bib226","article-title":"Establishment of bladder cancer spheroids and cultured in microfluidic platform for predicting drug response","volume":"9","author":"Xiong","year":"2023","journal-title":"Bioeng. Transl. Med."},{"key":"10.1016\/j.biomaterials.2026.124231_bib227","first-page":"1","article-title":"Krister Wennerberg A platform for efficient establishment and drug-response profiling of high-grade serous ovarian cancer organoids","volume":"58","author":"Wojciech Senkowski","year":"2023","journal-title":"Dev. Cell"},{"key":"10.1016\/j.biomaterials.2026.124231_bib228","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1291559","article-title":"Modeling of senescence-related chemoresistance in ovarian cancer using data analysis and patient-derived organoids","volume":"13","author":"Cai","year":"2024","journal-title":"Front. Oncol."},{"issue":"15","key":"10.1016\/j.biomaterials.2026.124231_bib229","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1158\/0008-5472.CAN-23-3007","article-title":"Human 3D ovarian cancer models reveal malignant cell instrinsic and extrinsic factors that influence CAR T cell activity","volume":"84","author":"Joash D Joy","year":"2024","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124231_bib232","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.3390\/cancers15041327","article-title":"Nano-electrochemical characterization of a 3D bioprinted cervical tumor model","volume":"15","author":"Becconi","year":"2023","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124231_bib233","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12645-023-00231-5","article-title":"Utilizing two-dimensional monolayer and three-dimensional spheroids to enhance radiotherapeutic potential by combining gold nanoparticles and docetaxel","volume":"14","author":"Bromma","year":"2023","journal-title":"Cancer Nanotechnol."},{"issue":"21","key":"10.1016\/j.biomaterials.2026.124231_bib234","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202302714","article-title":"Immunocompetent PDMS\u2010Free organ-on-chip model of cervical cancer integrating patient\u2010specific cervical fibroblasts and neutrophils","volume":"13","author":"Kromidas","year":"2024","journal-title":"Adv. Healthcare Mater."},{"issue":"24","key":"10.1016\/j.biomaterials.2026.124231_bib235","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1038\/s41388-024-03028-x","article-title":"Identification of genes that promote PI3K pathway activation and prostate tumour formation","volume":"43","author":"Francis","year":"2024","journal-title":"Oncogene"},{"issue":"10","key":"10.1016\/j.biomaterials.2026.124231_bib236","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.3390\/cells12101377","article-title":"Viability analysis and high-content live-cell imaging for drug testing in prostate cancer xenograft-derived organoids","volume":"12","author":"Van Hemelryk","year":"2023","journal-title":"Cells"},{"issue":"11","key":"10.1016\/j.biomaterials.2026.124231_bib243","doi-asserted-by":"crossref","first-page":"4621","DOI":"10.1016\/j.apsb.2023.04.010","article-title":"A biomimetic liver cancer on-a-chip reveals a critical role of LIPOCALIN-2 in promoting hepatocellular carcinoma progression","volume":"13","author":"Shen","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"issue":"11","key":"10.1016\/j.biomaterials.2026.124231_bib244","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1038\/s41587-023-01680-4","article-title":"Engineered human hepatocyte organoids enable CRISPR-based target discovery and drug screening for steatosis","volume":"41","author":"Hendriks","year":"2023","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.biomaterials.2026.124231_bib241","article-title":"Pharmaco-proteogenomic characterization of liver cancer organoids for precision oncology","volume":"15","author":"Shuyi Ji","year":"2023","journal-title":"Sci. Transl. Med."},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124231_bib242","doi-asserted-by":"crossref","DOI":"10.1088\/1758-5090\/ace3f9","article-title":"Spheroid on-demand printing and drug screening of endothelialized hepatocellular carcinoma model at different stages","volume":"15","author":"Liu","year":"2023","journal-title":"Biofabrication"},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124231_bib250","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.3390\/ijms23031166","article-title":"Spheroid culture differentially affects cancer cell sensitivity to drugs in melanoma and RCC models","volume":"23","author":"Filipiak-Duliban","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124231_bib247","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s11912-020-0892-1","article-title":"Current state of systemic therapies for advanced renal cell carcinoma","volume":"22","author":"Gulati","year":"2020","journal-title":"Curr. Oncol. Rep."},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124231_bib248","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1148\/rg.2019180178","article-title":"Current challenges in diagnosis and assessment of the response of locally advanced and metastatic renal cell carcinoma","volume":"39","author":"Diaz de Leon","year":"2019","journal-title":"Radiographics"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124231_bib249","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.semnephrol.2019.12.010","article-title":"Potential new therapeutic approaches for renal cell carcinoma","volume":"40","author":"Yang","year":"2020","journal-title":"Semin. Nephrol."},{"issue":"10","key":"10.1016\/j.biomaterials.2026.124231_bib128","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.mpdhp.2014.09.006","article-title":"Update on histologic classification of non-small cell lung cancer","volume":"20","author":"Moreira","year":"2014","journal-title":"Diagn. Histopathol."},{"issue":"21","key":"10.1016\/j.biomaterials.2026.124231_bib129","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232113306","article-title":"Comparison of EMT-related and multi-drug resistant gene expression, extracellular matrix production, and drug sensitivity in NSCLC spheroids generated by scaffold-free and scaffold-based methods","volume":"23","author":"Qi","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"38","key":"10.1016\/j.biomaterials.2026.124231_bib130","doi-asserted-by":"crossref","first-page":"10070","DOI":"10.1016\/j.biomaterials.2014.09.010","article-title":"Acquisition of epithelial\u2013mesenchymal transition and cancer stem-like phenotypes within chitosan-hyaluronan membrane-derived 3D tumor spheroids","volume":"35","author":"Huang","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2026.124231_bib131","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.actbio.2016.06.014","article-title":"Chitosan-hyaluronan based 3D co-culture platform for studying the crosstalk of lung cancer cells and mesenchymal stem cells","volume":"42","author":"Han","year":"2016","journal-title":"Acta Biomater."},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124231_bib132","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1039\/c8mt00369f","article-title":"Comparative antitumor studies of organoruthenium complexes with 8-hydroxyquinolines on 2D and 3D cell models of bone, lung and breast cancer","volume":"11","author":"Ruiz","year":"2019","journal-title":"Metallomics"},{"issue":"21","key":"10.1016\/j.biomaterials.2026.124231_bib133","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242115780","article-title":"Cellular effects of selected unsymmetrical bisacridines on the multicellular tumor spheroids of HCT116 Colon and A549 lung cancer cells in comparison to monolayer cultures","volume":"24","author":"Kulesza","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.biomaterials.2026.124231_bib134","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1002\/ijc.30913","article-title":"Coadministration of a tumor\u2010penetrating peptide improves the therapeutic efficacy of paclitaxel in a novel air\u2010grown lung cancer 3D spheroid model","volume":"141","author":"Gupta","year":"2017","journal-title":"Int. J. Cancer"},{"issue":"12","key":"10.1016\/j.biomaterials.2026.124231_bib135","doi-asserted-by":"crossref","first-page":"6570","DOI":"10.1021\/acsbiomaterials.9b00947","article-title":"Development and evaluation of paclitaxel-loaded aerosol nanocomposite microparticles and their efficacy against air-grown lung cancer tumor spheroids","volume":"5","author":"Torrico Guzm\u00e1n","year":"2019","journal-title":"ACS Biomater. Sci. Eng."},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124231_bib136","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.slasd.2023.01.005","article-title":"Protocol for 3D screening of lung cancer spheroids using natural products","volume":"28","author":"Vega","year":"2023","journal-title":"SLAS Discovery"},{"key":"10.1016\/j.biomaterials.2026.124231_bib144","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfa.2023.131288","article-title":"In vitro construction of lung cancer organoids by 3D bioprinting for drug evaluation","volume":"666","author":"Dong","year":"2023","journal-title":"Colloids Surf. A Physicochem. Eng. Asp."},{"issue":"12","key":"10.1016\/j.biomaterials.2026.124231_bib137","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1002\/cac2.12224","article-title":"Tumor organoids: synergistic applications, current challenges, and future prospects in cancer therapy","volume":"41","author":"Qu","year":"2021","journal-title":"Cancer Commun."},{"issue":"8","key":"10.1016\/j.biomaterials.2026.124231_bib138","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.101411","article-title":"Human lung adenocarcinoma-derived organoid models for drug screening","volume":"23","author":"Li","year":"2020","journal-title":"iScience"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124231_bib139","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1038\/s41467-019-11867-6","article-title":"Patient-derived lung cancer organoids as in vitro cancer models for therapeutic screening","volume":"10","author":"Kim","year":"2019","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.biomaterials.2026.124231_bib140","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1158\/1078-0432.CCR-19-1376","article-title":"Organoid cultures as preclinical models of non\u2013small cell lung cancer","volume":"26","author":"Shi","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biomaterials.2026.124231_bib141","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.canlet.2020.01.030","article-title":"Organoid models in lung regeneration and cancer","volume":"475","author":"Wang","year":"2020","journal-title":"Cancer Lett."},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124231_bib142","doi-asserted-by":"crossref","first-page":"788","DOI":"10.3390\/cancers12040788","article-title":"Dysregulated pyrimidine biosynthesis contributes to 5-FU resistance in SCLC patient-derived organoids but response to a novel polymeric fluoropyrimidine, CF10","volume":"12","author":"Gmeiner","year":"2020","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124231_bib145","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s13577-020-00331-z","article-title":"LncRNA GAS5-AS1 inhibits glioma proliferation, migration, and invasion via miR\u2010106b-5p\/TUSC2 axis","volume":"33","author":"Huang","year":"2020","journal-title":"Hum. Cell"},{"issue":"10","key":"10.1016\/j.biomaterials.2026.124231_bib146","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s11912-019-0834-y","article-title":"How we treat recurrent glioblastoma today and current evidence","volume":"21","author":"Chaul-Barbosa","year":"2019","journal-title":"Curr. Oncol. Rep."},{"issue":"11","key":"10.1016\/j.biomaterials.2026.124231_bib147","doi-asserted-by":"crossref","first-page":"5300","DOI":"10.1111\/jcmm.13793","article-title":"PLK1 inhibitor facilitates the suppressing effect of temozolomide on human brain glioma stem cells","volume":"22","author":"Liu","year":"2018","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.biomaterials.2026.124231_bib148","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1016\/j.wneu.2018.09.109","article-title":"Comparison of radiation therapy alone and chemotherapy alone for low-grade gliomas without surgical resection","volume":"122","author":"Wu","year":"2019","journal-title":"World Neurosurg."},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124231_bib149","doi-asserted-by":"crossref","first-page":"665","DOI":"10.7150\/thno.41692","article-title":"Glioma stem cells and their roles within the hypoxic tumor microenvironment","volume":"11","author":"Boyd","year":"2021","journal-title":"Theranostics"},{"issue":"12","key":"10.1016\/j.biomaterials.2026.124231_bib150","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3390\/brainsci7120166","article-title":"Advances in brain tumor surgery for glioblastoma in adults","volume":"7","author":"Lara-Velazquez","year":"2017","journal-title":"Brain Sci."},{"key":"10.1016\/j.biomaterials.2026.124231_bib151","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.16426","article-title":"Identification of potential glioma drug resistance target proteins based on ultra-performance liquid chromatography-mass spectrometry differential proteomics","volume":"11","author":"Li","year":"2023","journal-title":"PeerJ"},{"key":"10.1016\/j.biomaterials.2026.124231_bib152","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115410","article-title":"A high-density 3-dimensional culture model of human glioblastoma for rapid screening of therapeutic resistance","volume":"208","author":"Brown","year":"2023","journal-title":"Biochem. Pharmacol."},{"issue":"7","key":"10.1016\/j.biomaterials.2026.124231_bib154","doi-asserted-by":"crossref","DOI":"10.1002\/adtp.201800058","article-title":"Crosslinked Chitosan\u2010PEG hydrogel for culture of human glioblastoma cell spheroids and drug screening","volume":"1","author":"Chang","year":"2018","journal-title":"Adv. Therapeut."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124231_bib155","article-title":"Engineering a brain cancer chip for high-throughput drug screening","volume":"6","author":"Fan","year":"2016","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124231_bib156","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s10544-018-0322-4","article-title":"Engineered 3D tumour model for study of glioblastoma aggressiveness and drug evaluation on a detachably assembled microfluidic device","volume":"20","author":"Ma","year":"2018","journal-title":"Biomed. Microdevices"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124231_bib157","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-22439-y","article-title":"Hydrogel-based microfluidic device with multiplexed 3D in vitro cell culture","volume":"12","author":"Clancy","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biomaterials.2026.124231_bib166","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.biomaterials.2018.07.048","article-title":"A three-dimensional (3D) organotypic microfluidic model for glioma stem cells \u2013 vascular interactions","volume":"198","author":"Truong","year":"2019","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124231_bib175","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3390\/ijms18010197","article-title":"Colorectal carcinoma: a general overview and future perspectives in colorectal cancer","volume":"18","author":"M\u00e1rmol","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124231_bib176","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.pathol.2017.09.004","article-title":"Pathology and genetics of hereditary colorectal cancer","volume":"50","author":"Ma","year":"2018","journal-title":"Pathology"},{"issue":"8","key":"10.1016\/j.biomaterials.2026.124231_bib177","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1177\/2050640618783554","article-title":"Features of incident colorectal cancer in Lynch syndrome","volume":"6","author":"Argillander","year":"2018","journal-title":"United Eur. Gastroenterol. J."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124231_bib178","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ajpath.2011.03.015","article-title":"Modeling Colon adenocarcinomas in vitro","volume":"179","author":"Dolznig","year":"2011","journal-title":"Am. J. Pathol."},{"issue":"12","key":"10.1016\/j.biomaterials.2026.124231_bib179","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1038\/onc.2014.86","article-title":"Targeting colon cancer cell NF-\u03baB promotes an anti-tumour M1-like macrophage phenotype and inhibits peritoneal metastasis","volume":"34","author":"Ryan","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.biomaterials.2026.124231_bib180","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.trsl.2018.02.002","article-title":"NF-\u03baB pathways in the development and progression of colorectal cancer","volume":"197","author":"Patel","year":"2018","journal-title":"Transl. Res."},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124231_bib181","article-title":"Short-term spheroid culture of primary colorectal cancer cells as an in vitro model for personalizing cancer medicine","volume":"12","author":"Wu","year":"2017","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124231_bib182","doi-asserted-by":"crossref","first-page":"501","DOI":"10.2967\/jnumed.109.065706","article-title":"Of mice and humans: are they the same?\u2014implications in cancer translational research: table 1","volume":"51","author":"de Jong","year":"2010","journal-title":"J. Nucl. Med."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124231_bib183","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s40425-019-0553-9","article-title":"Cocultures of human colorectal tumor spheroids with immune cells reveal the therapeutic potential of MICA\/B and NKG2A targeting for cancer treatment","volume":"7","author":"Courau","year":"2019","journal-title":"J. ImmunoTher. Cancer"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124231_bib184","doi-asserted-by":"crossref","first-page":"7103","DOI":"10.1038\/s41598-019-42836-0","article-title":"Short-term 3D culture systems of various complexity for treatment optimization of colorectal carcinoma","volume":"9","author":"Zoetemelk","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biomaterials.2026.124231_bib185","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ejca.2019.07.005","article-title":"Cancer invasion regulates vascular complexity in a three-dimensional biomimetic model","volume":"119","author":"Pape","year":"2019","journal-title":"Eur. J. Cancer"},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124231_bib186","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1111\/cas.12720","article-title":"Assessment of elasticity of colorectal cancer tissue, clinical utility, pathological and phenotypical relevance","volume":"106","author":"Kawano","year":"2015","journal-title":"Cancer Sci."},{"issue":"14","key":"10.1016\/j.biomaterials.2026.124231_bib187","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1038\/onc.2012.202","article-title":"Lysyl oxidase enzymatic function increases stiffness to drive colorectal cancer progression through FAK","volume":"32","author":"Baker","year":"2012","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124231_bib188","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1002\/btpr.30","article-title":"Biomimetic macroporous hydrogel scaffolds in a high\u2010throughput screening format for cell\u2010based assays","volume":"24","author":"Dainiak","year":"2008","journal-title":"Biotechnol. Prog."},{"issue":"7244","key":"10.1016\/j.biomaterials.2026.124231_bib189","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/nature07935","article-title":"Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche","volume":"459","author":"Sato","year":"2009","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.biomaterials.2026.124231_bib190","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1053\/j.gastro.2011.07.050","article-title":"Long-term expansion of epithelial organoids from human Colon, adenoma, adenocarcinoma, and Barrett's epithelium","volume":"141","author":"Sato","year":"2011","journal-title":"Gastroenterology"},{"issue":"43","key":"10.1016\/j.biomaterials.2026.124231_bib191","doi-asserted-by":"crossref","first-page":"13308","DOI":"10.1073\/pnas.1516689112","article-title":"Preserved genetic diversity in organoids cultured from biopsies of human colorectal cancer metastases","volume":"112","author":"Weeber","year":"2015","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"12","key":"10.1016\/j.biomaterials.2026.124231_bib192","doi-asserted-by":"crossref","first-page":"E2357","DOI":"10.1073\/pnas.1701219114","article-title":"Genetic dissection of colorectal cancer progression by orthotopic transplantation of engineered cancer organoids","volume":"114","author":"Fumagalli","year":"2017","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124231_bib193","doi-asserted-by":"crossref","first-page":"dev153049","DOI":"10.1242\/dev.153049","article-title":"Identification, isolation and characterization of human LGR5-positive colon adenoma cells","volume":"145","author":"Dame","year":"2018","journal-title":"Development"},{"issue":"40","key":"10.1016\/j.biomaterials.2026.124231_bib194","doi-asserted-by":"crossref","first-page":"5263","DOI":"10.1038\/onc.2016.60","article-title":"Collagen-rich stroma in aggressive colon tumors induces mesenchymal gene expression and tumor cell invasion","volume":"35","author":"Vellinga","year":"2016","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124231_bib195","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.cell.2015.03.053","article-title":"Prospective derivation of a living organoid biobank of colorectal cancer patients","volume":"161","author":"van de Wetering","year":"2015","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124231_bib196","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.stem.2019.10.010","article-title":"Patient-derived organoids predict chemoradiation responses of locally advanced rectal cancer","volume":"26","author":"Yao","year":"2020","journal-title":"Cell Stem Cell"},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124231_bib197","doi-asserted-by":"crossref","first-page":"923","DOI":"10.3390\/cancers12040923","article-title":"Ex vivo organoid cultures reveal the importance of the tumor microenvironment for maintenance of colorectal cancer stem cells","volume":"12","author":"Li","year":"2020","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124231_bib198","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41698-020-0117-y","article-title":"Multiplexed drug testing of tumor slices using a microfluidic platform","volume":"4","author":"Horowitz","year":"2020","journal-title":"npj Precis. Oncol."},{"issue":"5","key":"10.1016\/j.biomaterials.2026.124231_bib199","doi-asserted-by":"crossref","first-page":"eaaw1317","DOI":"10.1126\/sciadv.aaw1317","article-title":"Colorectal tumor-on-a-chip system: a 3D tool for precision onco-nanomedicine","volume":"5","author":"Carvalho","year":"2019","journal-title":"Sci. Adv."},{"issue":"7","key":"10.1016\/j.biomaterials.2026.124231_bib200","article-title":"Co-Culture of tumor spheroids and fibroblasts in a collagen matrix-incorporated microfluidic chip mimics reciprocal activation in solid tumor microenvironment","volume":"11","author":"Lee","year":"2016","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124231_bib201","first-page":"964","article-title":"A gastric cancer patient-derived three-dimensional cell spheroid culture model","volume":"13","author":"Hua Zhang","year":"2023","journal-title":"Am. J. Cancer Res."},{"issue":"28","key":"10.1016\/j.biomaterials.2026.124231_bib202","doi-asserted-by":"crossref","DOI":"10.3346\/jkms.2022.37.e220","article-title":"Establishment of patient-derived gastric cancer organoid model from tissue obtained by endoscopic biopsies","volume":"37","author":"Song","year":"2022","journal-title":"J. Kor. Med. Sci."},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124231_bib203","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1245\/s10434-018-6662-8","article-title":"Development of patient-derived gastric cancer organoids from endoscopic biopsies and surgical tissues","volume":"25","author":"Gao","year":"2018","journal-title":"Ann. Surg Oncol."},{"key":"10.1016\/j.biomaterials.2026.124231_bib204","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114751","article-title":"Patient-derived organoid culture of gastric cancer for disease modeling and drug sensitivity testing","volume":"163","author":"Zu","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124231_bib205","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbagen.2024.130566","article-title":"Gastric cancer patient-derived organoids model for the therapeutic drug screening","volume":"1868","author":"Xu","year":"2024","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124231_bib230","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41378-020-00201-6","article-title":"A microfluidic platform for cultivating ovarian cancer spheroids and testing their responses to chemotherapies","volume":"6","author":"Dadgar","year":"2020","journal-title":"Microsyst. Nanoeng."},{"issue":"12","key":"10.1016\/j.biomaterials.2026.124231_bib231","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202302340","article-title":"A promising new model: establishment of patient\u2010derived organoid models covering HPV\u2010Related cervical pre\u2010cancerous lesions and their cancers","volume":"11","author":"Hu","year":"2024","journal-title":"Adv. Sci."},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124231_bib237","doi-asserted-by":"crossref","first-page":"3511","DOI":"10.1007\/s12010-023-04700-w","article-title":"Sustainable nanoparticles from Stephania glabra and analysis of their anticancer potential on 2D and 3D models of prostate cancer","volume":"196","author":"Vaid","year":"2023","journal-title":"Appl. Biochem. Biotechnol."},{"key":"10.1016\/j.biomaterials.2026.124231_bib238","article-title":"Microfluidic-based human prostate-cancer-on-chip","volume":"12","author":"Jiang","year":"2024","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"10360","key":"10.1016\/j.biomaterials.2026.124231_bib239","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0140-6736(22)01200-4","article-title":"Hepatocellular carcinoma","volume":"400","author":"Arndt Vogel","year":"2022","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124231_bib240","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41575-021-00508-3","article-title":"Cancer stem cells in hepatocellular carcinoma \u2014 from origin to clinical implications","volume":"19","author":"Lee","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"27","key":"10.1016\/j.biomaterials.2026.124231_bib245","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202302640","article-title":"Micro\u2010engineered organoid-on-a-chip based on mesenchymal stromal cells to predict immunotherapy responses of HCC patients","volume":"10","author":"Zou","year":"2023","journal-title":"Adv. Sci."},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124231_bib246","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.ucl.2020.07.009","article-title":"Kidney cancer: an overview of current therapeutic approach","volume":"47","author":"Chowdhury","year":"2020","journal-title":"Urol. Clin."},{"issue":"12","key":"10.1016\/j.biomaterials.2026.124231_bib251","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.7432","article-title":"The establishment of kidney cancer organoid line in drug testing","volume":"13","author":"Tse","year":"2024","journal-title":"Cancer Med."},{"key":"10.1016\/j.biomaterials.2026.124231_bib252","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2023.100948","article-title":"Therapeutic targeting of tumor spheroids in a 3D microphysiological renal cell carcinoma-on-a-chip system","volume":"46","author":"Miller","year":"2023","journal-title":"Neoplasia"},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124231_bib253","doi-asserted-by":"crossref","first-page":"3750","DOI":"10.1021\/acsabm.3c00421","article-title":"3D cell printing of advanced vascularized proximal Tubule-on-a-Chip for drug induced nephrotoxicity advancement","volume":"6","author":"Singh","year":"2023","journal-title":"ACS Appl. Bio Mater."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124231_bib254","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3390\/mi13010003","article-title":"Drug-induced nephrotoxicity assessment in 3D cellular models","volume":"13","author":"Yu","year":"2021","journal-title":"Micromachines"},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124231_bib255","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.xphs.2021.01.028","article-title":"Implementation of a human renal proximal tubule on a chip for nephrotoxicity and drug interaction studies","volume":"110","author":"Vormann","year":"2021","journal-title":"J. Pharmaceut. Sci."},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124231_bib256","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00535-017-1338-x","article-title":"Esophageal cancer stem cells are suppressed by tranilast, a TRPV2 channel inhibitor","volume":"53","author":"Shiozaki","year":"2017","journal-title":"J. Gastroenterol."},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124231_bib257","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1021\/acsbiomaterials.1c01099","article-title":"Vascularized tumor Spheroid-on-a-Chip model verifies synergistic vasoprotective and chemotherapeutic effects","volume":"8","author":"Hu","year":"2022","journal-title":"ACS Biomater. Sci. Eng."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124231_bib258","doi-asserted-by":"crossref","DOI":"10.1002\/cpsc.109","article-title":"Generation and characterization of patient\u2010derived head and neck, oral, and esophageal cancer organoids","volume":"53","author":"Karakasheva","year":"2020","journal-title":"Current Protocols in Stem Cell Biology"},{"issue":"28","key":"10.1016\/j.biomaterials.2026.124231_bib260","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202401458","article-title":"Bioengineered silk protein\u2010based 3D in vitro models for tissue engineering and drug development: from silk matrix properties to biomedical applications","volume":"13","author":"Shuai","year":"2024","journal-title":"Adv. Healthcare Mater."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124231_bib261","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jhep.2024.06.040","article-title":"Induction of steatosis in primary human hepatocytes recapitulates key pathophysiological aspects of metabolic dysfunction-associated steatotic liver disease","volume":"82","author":"Kwon","year":"2025","journal-title":"J. Hepatol."},{"issue":"8","key":"10.1016\/j.biomaterials.2026.124231_bib262","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202302905","article-title":"An improved understanding of the pathophysiology of pelvic organ prolapse: a 3D in vitro model under static and mechanical loading conditions","volume":"13","author":"van Velthoven","year":"2024","journal-title":"Adv. Healthcare Mater."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124231_bib263","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.1038\/s41467-025-59042-4","article-title":"A microengineered 3D human neurovascular unit model to probe the neuropathogenesis of herpes simplex encephalitis","volume":"16","author":"Zhang","year":"2025","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124231_bib264","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1631\/bdm.2400424","article-title":"Vascularized organoid-on-a-chip for centimeter-scale organoid cultivation","volume":"8","author":"Gong","year":"2025","journal-title":"BioDes. Manuf."},{"key":"10.1016\/j.biomaterials.2026.124231_bib265","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1056\/NEJMra1010600","article-title":"Genomics and drug response","volume":"364","author":"Gregory Feero","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124231_bib266","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.tips.2004.02.007","article-title":"Pharmacogenetics of cytochrome P450 and its applications in drug therapy: the past, present and future","volume":"25","author":"Ingelman-Sundberg","year":"2004","journal-title":"Trends Pharmacol. Sci."},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124231_bib267","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nrg1428","article-title":"Pharmacogenetics - five decades of therapeutic lessons from genetic diversity","volume":"5","author":"Meyer","year":"2004","journal-title":"Nat. Rev. Genet."},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124231_bib268","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/JTO.0b013e3181c814e7","article-title":"Adjuvant cisplatin and vinorelbine for completely resected non-small cell lung cancer subgroup analysis of the lung adjuvant cisplatin evaluation","volume":"5","author":"Jean-Yves Douillard","year":"2010","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.biomaterials.2026.124231_bib269","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1056\/NEJMoa0810699","article-title":"Gefitinib or carboplatin\u2013paclitaxel in pulmonary adenocarcinoma","volume":"361","author":"Mok","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.biomaterials.2026.124231_bib270","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/S1470-2045(21)00288-6","article-title":"Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials","volume":"22","author":"Bradley","year":"2021","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.biomaterials.2026.124231_bib271","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1126\/science.aao2774","article-title":"Patient-derived organoids model treatment response of metastatic gastrointestinal cancers","volume":"359","author":"Georgios Vlachogiannis","year":"2018","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124231_bib272","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1186\/s12967-025-06593-1","article-title":"Patient-derived esophageal adenocarcinoma organ chip: a physiologically relevant platform for functional precision oncology","volume":"23","author":"Pal","year":"2025","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124231_bib273","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/s41698-025-01082-6","article-title":"PharmaFormer predicts clinical drug responses through transfer learning guided by patient derived organoid","volume":"9","author":"Zhou","year":"2025","journal-title":"npj Precis. Oncol."},{"issue":"8","key":"10.1016\/j.biomaterials.2026.124231_bib274","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003370","article-title":"Nomogram to predict the outcomes of patients with microsatellite instability-high metastatic colorectal cancer receiving immune checkpoint inhibitors","volume":"9","author":"Pietrantonio","year":"2021","journal-title":"J. ImmunoTher. Cancer"},{"key":"10.1016\/j.biomaterials.2026.124231_bib275","doi-asserted-by":"crossref","first-page":"4231","DOI":"10.1200\/JCO.20.01932","article-title":"Randomized, phase III trial of neoadjuvant chemoradiation with capecitabine and irinotecan guided by UGT1A1 status in patients with locally advanced rectal cancer","volume":"38","author":"Ji Zhu","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.biomaterials.2026.124231_bib276","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/s41565-025-01918-z","article-title":"Nanopore-based enzyme-linked immunosorbent assay for cancer biomarker detection","volume":"20","author":"Yi","year":"2025","journal-title":"Nat. Nanotechnol."},{"issue":"12","key":"10.1016\/j.biomaterials.2026.124231_bib277","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1158\/2159-8290.CD-23-0313","article-title":"Ultrasensitive detection of circulating LINE-1 ORF1p as a specific multicancer biomarker","volume":"13","author":"Taylor","year":"2023","journal-title":"Cancer Discov."},{"issue":"14","key":"10.1016\/j.biomaterials.2026.124231_bib278","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1056\/NEJMc2408121","article-title":"Pembrolizumab in HER2-Positive gastric cancer","volume":"391","author":"Yelena Y Janjigian","year":"2024","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124231_bib279","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/s41591-023-02791-w","article-title":"Baseline ctDNA gene alterations as a biomarker of survival after panitumumab and chemotherapy in metastatic colorectal cancer","volume":"30","author":"Shitara","year":"2024","journal-title":"Nat. Med."},{"issue":"7","key":"10.1016\/j.biomaterials.2026.124231_bib280","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.3324\/haematol.2018.189837","article-title":"Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: a GIMEMA, ERIC and UK CLL FORUM study","volume":"103","author":"Cuneo","year":"2018","journal-title":"Haematologica"},{"issue":"11","key":"10.1016\/j.biomaterials.2026.124231_bib281","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1001\/jamaoncol.2018.2969","article-title":"Assessment of resistance mechanisms and clinical implications in patients WithEGFRT790M\u2013Positive lung cancer and acquired resistance to osimertinib","volume":"4","author":"Oxnard","year":"2018","journal-title":"JAMA Oncol."},{"issue":"5","key":"10.1016\/j.biomaterials.2026.124231_bib282","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.cell.2024.01.042","article-title":"Past, present, and future of CRISPR genome editing technologies","volume":"187","author":"Pacesa","year":"2024","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124231_bib283","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1007\/s12264-021-00732-6","article-title":"Co-editing PINK1 and DJ-1 genes via adeno-associated virus-delivered CRISPR\/Cas9 system in adult monkey brain elicits classical parkinsonian phenotype","volume":"37","author":"Li","year":"2021","journal-title":"Neurosci. Bull."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124231_bib284","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13073-019-0627-9","article-title":"CRISPR-SONIC: targeted somatic oncogene knock-in enables rapid in vivo cancer modeling","volume":"11","author":"Mou","year":"2019","journal-title":"Genome Med."},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124231_bib285","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/s41591-018-0327-9","article-title":"Development of a gene-editing approach to restore vision loss in Leber congenital amaurosis type 10","volume":"25","author":"Maeder","year":"2019","journal-title":"Nat. Med."},{"issue":"20","key":"10.1016\/j.biomaterials.2026.124231_bib286","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202419912","article-title":"Advances and challenges in human 3D solid tumor models","volume":"35","author":"Natesh","year":"2025","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.biomaterials.2026.124231_bib287","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1162905","article-title":"Opportunities and challenges to engineer 3D models of tumor-adaptive immune interactions","volume":"14","author":"Visalakshan","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biomaterials.2026.124231_bib288","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2024.150339","article-title":"Advances in tumor microenvironment: applications and challenges of 3D bioprinting","volume":"730","author":"Dong","year":"2024","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124231_bib289","doi-asserted-by":"crossref","DOI":"10.1088\/1758-5090\/ae3645","article-title":"Self-driving bioprinting laboratories","volume":"18","author":"Liu","year":"2026","journal-title":"Biofabrication"}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961226002553?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961226002553?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T10:35:41Z","timestamp":1783074941000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961226002553"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":280,"alternative-id":["S0142961226002553"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2026.124231","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Physiologically relevant 3D tumor models for therapeutic screening","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2026.124231","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"124231"}}